Amir Nashat, Director at FATE THERAPEUTICS INC (FATE), sold 176,844 shares at $14.14 ($2.5M) on 2019-01-25, disclosed to the SEC on 2019-01-29.
Open-market sale of $2.5M FATE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.14 | 595 | $8K | 0.3% |
| 2 | $14.14 | 868 | $12K | 0.5% |
| 3 | $14.14 | 1,693 | $24K | 1.0% |
| 4 | $14.14 | 86,844 | $1.2M | 49.1% |
| 5 | $14.14 | 86,844 | $1.2M | 49.1% |
| Total | $14.14 avg | 176,844 |
| $2.5M |
| 100% |
| Filing → |
| SRRK | BUY | 2022-06-24 | $6.2M | — | Filing → |
| MORF | SELL | 2021-05-25 | $20.4M | — | Filing → |
| MTCR | BUY | 2020-09-22 | $3.0M | — | Filing → |